Genome methylation accurately predicts neuroendocrine tumor origin - an online tool.

CONCLUSIONS: This DNA methylation-based prediction model can be used in the workup for patients with neuroendocrine tumors of unknown primary. To facilitate validation and clinical implementation, we provide a user-friendly, publicly available web-based version of NEN-ID.
PMID: 33355250 [PubMed - as supplied by publisher]

Source: Clinical Cancer Research - December 22, 2020 Category: Cancer & Oncology Authors: Hackeng WM, Dreijerink KMA, de Leng WWJ, Morsink FH, Valk GD, Vriens MR, Offerhaus GJA, Geisenberger C, Brosens LAA Tags: Clin Cancer Res Source Type: research